Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Morgan

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Cancers|June 2, 2021
The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma SurveillanceShari S Rogal, Vera Yakovchenko, Rachel Gonzalez, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok, Marc G Ghany, Zachary D Goodman, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Journal of Hepatology|September 2, 2005
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, et al.
The American Journal of Pathology|October 15, 2022
Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated HepatitisJosepmaria Argemi, Komal Kedia, Marina A Gritsenko, et al.
Implementation Science : IS|August 9, 2025
Comparing the effectiveness of implementation strategies to improve liver and colon cancer screening for Veterans: protocol for a large cluster-randomized implementation studyShari S Rogal, Vera Yakovchenko, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|February 6, 2022
Core implementation strategies for improving cirrhosis care in the Veterans Health AdministrationVera Yakovchenko, Timothy R Morgan, Edward J Miech, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 22, 2015
A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectumDaniel L Gillen, Frank L Meyskens, Timothy R Morgan, et al.
Gastroenterology|May 4, 2015
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic HepatitisAlexandre Louvet, Julien Labreuche, Florent Artru, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Cancers|June 2, 2021
The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma SurveillanceShari S Rogal, Vera Yakovchenko, Rachel Gonzalez, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok, Marc G Ghany, Zachary D Goodman, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Journal of Hepatology|September 2, 2005
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, et al.
The American Journal of Pathology|October 15, 2022
Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated HepatitisJosepmaria Argemi, Komal Kedia, Marina A Gritsenko, et al.
Implementation Science : IS|August 9, 2025
Comparing the effectiveness of implementation strategies to improve liver and colon cancer screening for Veterans: protocol for a large cluster-randomized implementation studyShari S Rogal, Vera Yakovchenko, Timothy R Morgan, et al.
Hepatology (Baltimore, Md.)|February 6, 2022
Core implementation strategies for improving cirrhosis care in the Veterans Health AdministrationVera Yakovchenko, Timothy R Morgan, Edward J Miech, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 22, 2015
A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectumDaniel L Gillen, Frank L Meyskens, Timothy R Morgan, et al.
Gastroenterology|May 4, 2015
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic HepatitisAlexandre Louvet, Julien Labreuche, Florent Artru, et al.
Pageof 18